News

Weight loss drugs Ozempic and Wegovy would no longer be covered by California’s health insurance for low-income people under ...
From 2015 and 2021, almost 30% of deaths among residents and fellows were due to suicide. In other news: Medicare fraud at UnitedHealth; patient fall rates at rehab facilities; and more.
Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...
Shares of Septerna SEPN surged 51% on May 14 after the company entered into an exclusive global collaboration and license ...
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...
CompanyOverview|NYSE:NVO] Despite a double beat in its quarterly earnings on May 7, Novo Nordisk A/S (NYSE: NVO) stock is ...
A global trial reveals tirzepatide helps people lose more weight faster than semaglutide. This breakthrough could change ...